KRISTEN KUVEIKIS: Open Payments
NPI 1710566443 · LANCASTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 23 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $181 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $138 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Corcept Therapeutics | 1 | $24 |
| Indivior Inc. | 1 | $21 |
Products named: VRAYLAR, FANAPT, Auvelity, CAPLYTA, Korlym, QULIPTA, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
